SMYTH MARK S has a total of 13 patent applications. Its first patent ever was published in 2005. It filed its patents most often in United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are ENKAM PHARMACEUTICALS AS, SANDOZ PHARMA UK and THERAPTOSIS S A.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 13 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Peptides | |
#3 | Climate change adaptation technologies | |
#4 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Smyth Mark S | 13 |
#2 | Laidig Guy J | 13 |
#3 | Borchardt Ronald T | 6 |
#4 | Crews Craig M | 6 |
#5 | Bunin Barry A | 6 |
#6 | Musser John H | 6 |
#7 | Shenk Kevin D | 3 |
#8 | Radel Peggy A | 3 |
Publication | Filing date | Title |
---|---|---|
US2009131421A1 | Compounds for proteasome enzyme inhibition |